Skip to main content
Year archive

SHIELD THERAPEUTICS PLC — 2017 filings

All 24 regulatory filings released by SHIELD THERAPEUTICS PLC (STX) in 2017, sourced directly from the official regulator.

24 Filings
2017 Period
2017 filings (24)
Filing Released Lang
Completion of patient enrolment in Phase 3 study
Legal Proceedings Report
2017-10-10 English
PDMR Acquisition of Shares
Director's Dealing
2017-10-05 English
Interim Report
Interim / Quarterly Report H1 2017
2017-09-20 English
Board Change
Board/Management Information
2017-09-14 English
US Composition of Matter Patent Allowed
Legal Proceedings Report
2017-09-06 English
Shield to Present at Baird Healthcare Conference
Regulatory Filings
2017-08-31 English
Notice of Results
Report Publication Announcement
2017-08-15 English
Grant of Share Options
Remuneration Information
2017-07-11 English
Holding(s) in Company
Major Shareholding Notification
2017-07-10 English
Feraccru licence agreement for Switzerland
Regulatory Filings
2017-07-06 English
Holding(s) in Company
Major Shareholding Notification
2017-07-05 English
Warrant Exercise and Expiry
Regulatory Filings
2017-07-03 English
Holding(s) in Company
Major Shareholding Notification
2017-06-28 English
Admission of New Ordinary Shares
Share Issue/Capital Change
2017-06-28 English
Biomarker data on ferric maltol in patients
Regulatory Filings
2017-06-22 English
Results of Fundraise
Share Issue/Capital Change
2017-06-15 English
Proposed Fundraise
Capital/Financing Update
2017-06-15 English
Result of AGM
AGM Information
2017-06-13 English
Appointment of Joint Broker
Regulatory Filings
2017-05-26 English
Annual Report, Accounts and AGM Notification
AGM Information
2017-04-28 English
Appointment of Chief Financial Officer
Board/Management Information
2017-04-04 English
Preliminary Results for the Year Ended 31 Dec 2016
Earnings Release FY 2016
2017-04-04 English
Notice of Results
Report Publication Announcement
2017-03-13 English
IP Portfolio Update
Regulatory Filings
2017-03-13 English